KCNMB2-AS1

Across TCGA pan-cancer cohorts, KCNMB2-AS1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated KCNMB2-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher KCNMB2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KCNMB2-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and ACC show a favorable association.

KIRC, KICH, and COAD are the cancer types where KCNMB2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.550	0.699	<.001	116	view →
KICH	OS	Tertile	III,IV	0.259	1.000	<.001	72	view →
COAD	DFS	Quartile	All	0.534	0.791	.001	47	view →
LUSC	OS	Median	All	0.831	0.717	<.001	43	view →
KIRP	OS	Quartile	III,IV	0.201	0.664	.003	23	view →
ACC	OS	Median	II,III,IV	1.000	0.659	<.001	23	view →
STAD	OS	Quartile	III,IV	0.386	0.640	.010	20	view →
SKCM	OS	Median	All	0.905	0.836	.004	17	view →
CESC	DFS	Median	All	0.457	0.642	.021	16	view →
READ	DFS	Quartile	All	0.909	0.475	.004	15	view →
MESO	OS	Quartile	All	0.255	0.470	.014	13	view →
UVM	OS	Median	III,IV	0.296	1.000	.006	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

KCNMB2-AS1–KIRC (OS)

Open the KIRC breakdown →